Using machine learning, an electronic nose can "smell" early signs of ovarian cancer in the blood. The method is precise and, ...
Researchers have developed an electronic nose that can “smell” early signs of ovarian cancer in the blood. The method is ...
Using machine learning, an electronic nose can "smell" early signs of ovarian cancer in the blood. The method is precise and, ...
Ovarian cancer is often referred to as the “silent killer” because its symptoms can be subtle and easily mistaken for common digestive or menstrual issues. However, for Black women, the silence ...
LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced an expansion of its collaboration with The University of Texas MD ...
A blood sample does not have an obvious odor to a person in a lab coat. But to an electronic nose, it can carry a chemical signature that points toward disease.
NorthX Biologics and Demeetra are collaborating to help biotech companies reach Investigational New Drug and clinical ...
(“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule therapies targeting p53, today announced that results from the ...
Seedless fruits are highly valued for their superior edible quality and consumer appeal, yet the biological mechanisms that allow fruits to develop ...
And that was also presented at ASH 2025 and also a very, very strong data set. I should mention that BI-1808 that was monotherapy, single-agent therapy. Then, we also started our Phase IIa trial ...
Accent Therapeutics has halted work on a solid tumor drug due to adverse events in a phase 1/2 study. | Accent Therapeutics has halted work on a solid tumor drug due to adverse events in a phase 1/2 ...
CAR T cell therapy has revolutionized the treatment of many blood cancers, but has shown little success against solid tumors, which account for over 85% of all cancers. Columbia researchers have now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results